Solupharm GmbH
NDC Database

Solupharm GmbH

NDC Database

National Drug Code (NDC) records including drug products, NDC numbers, nonproprietary names, dosage forms, strengths, labelers and marketing information.

Drug for Further Processing
  • Total Records 5
  • Latest Marketing Date 2019-04-02
  • Data Source FDA
  • First Marketing Date 2008-04-24
Company Overview

Company

Solupharm GmbH

Country

Germany

Social Profiles

Company Snapshot

Solupharm GmbH

IndustriestraßE 1

Germany

www.solupharm.com/ info@solupharm.com View on Map
NDC Records ( 5 records )
2019
02 Apr
Drug for Further Processing NDC: 55579-397

Nonproprietary Name

Bupivacaine Hydrochloride

Dosage Form

LIQUID

Strength

7.5 mg/mL

Labeler

Solupharm Pharmazeutische Erzeugnisse GmbH

Marketing Category

DRUG FOR FURTHER PROCESSING

55579-397

Substance

BUPIVACAINE HYDROCHLORIDE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2019-04-02

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2008
24 Apr
Drug for Further Processing NDC: 55579-401

Nonproprietary Name

PROMETHAZINE HYDROCHLORIDE

Dosage Form

INJECTION, SOLUTION

Strength

25 mg/mL

Labeler

Solupharm Pharmazeutische Erzeugnisse GmbH

Marketing Category

DRUG FOR FURTHER PROCESSING

55579-401

Substance

PROMETHAZINE HYDROCHLORIDE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2008-04-24

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2008
24 Apr
Drug for Further Processing NDC: 55579-402

Nonproprietary Name

PROMETHAZINE HYDROCHLORIDE

Dosage Form

INJECTION, SOLUTION

Strength

50 mg/mL

Labeler

Solupharm Pharmazeutische Erzeugnisse GmbH

Marketing Category

DRUG FOR FURTHER PROCESSING

55579-402

Substance

PROMETHAZINE HYDROCHLORIDE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2008-04-24

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2016
09 Aug
Drug for Further Processing NDC: 55579-937

Nonproprietary Name

Sodium Chloride

Dosage Form

LIQUID

Strength

9 mg/mL

Labeler

Solupharm Pharmazeutische Erzeugnisse GmbH

Marketing Category

DRUG FOR FURTHER PROCESSING

55579-937

Substance

SODIUM CHLORIDE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2016-08-09

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2018
03 Aug
Drug for Further Processing NDC: 55579-939

Nonproprietary Name

LIDOCAINE HYDROCHLORIDE

Dosage Form

LIQUID

Strength

10 mg/mL

Labeler

Solupharm Pharmazeutische Erzeugnisse GmbH

Marketing Category

DRUG FOR FURTHER PROCESSING

55579-939

Substance

LIDOCAINE HYDROCHLORIDE ANHYDROUS

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2018-08-03

End Marketing Date

-

Listing Record Certified Through

2026-12-31

Related Databases
  • FDA Inspections
    5 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    5 View
  • FDA Approved Drugs Database
    0 View
  • Drug Prices in Switzerland
    0 View
NDC Type Breakdown
5 total
  • Drug for Further Processing
Official Source

NDC data is based on publicly available National Drug Code information from the U.S. Food and Drug Administration (FDA).

Visit FDA NDC Directory
NDC Record Details Preview

Explore important National Drug Code information available in the records above.

NDC

55579-397

Nonproprietary Name

Bupivacaine Hydrochloride

Labeler

Solupharm Pharmazeutische Erzeugnisse GmbH

Dosage Form

LIQUID

FDA NDC Data

National Drug Code information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized NDC records

NDC data is based on publicly available U.S. Food and Drug Administration (FDA) National Drug Code information.

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.